1. Home
  2. TMDX vs EEFT Comparison

TMDX vs EEFT Comparison

Compare TMDX & EEFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • EEFT
  • Stock Information
  • Founded
  • TMDX 1998
  • EEFT 1994
  • Country
  • TMDX United States
  • EEFT United States
  • Employees
  • TMDX N/A
  • EEFT N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • EEFT EDP Services
  • Sector
  • TMDX Health Care
  • EEFT Technology
  • Exchange
  • TMDX Nasdaq
  • EEFT Nasdaq
  • Market Cap
  • TMDX 4.7B
  • EEFT 4.5B
  • IPO Year
  • TMDX 2019
  • EEFT 1997
  • Fundamental
  • Price
  • TMDX $88.36
  • EEFT $102.19
  • Analyst Decision
  • TMDX Buy
  • EEFT Buy
  • Analyst Count
  • TMDX 10
  • EEFT 8
  • Target Price
  • TMDX $138.20
  • EEFT $126.14
  • AVG Volume (30 Days)
  • TMDX 2.2M
  • EEFT 296.3K
  • Earning Date
  • TMDX 10-28-2024
  • EEFT 10-23-2024
  • Dividend Yield
  • TMDX N/A
  • EEFT N/A
  • EPS Growth
  • TMDX N/A
  • EEFT 27.95
  • EPS
  • TMDX 0.94
  • EEFT 6.88
  • Revenue
  • TMDX $401,090,000.00
  • EEFT $3,900,200,000.00
  • Revenue This Year
  • TMDX $83.25
  • EEFT $10.36
  • Revenue Next Year
  • TMDX $26.27
  • EEFT $7.91
  • P/E Ratio
  • TMDX $94.29
  • EEFT $14.85
  • Revenue Growth
  • TMDX 109.09
  • EEFT 8.46
  • 52 Week Low
  • TMDX $63.86
  • EEFT $81.99
  • 52 Week High
  • TMDX $177.37
  • EEFT $117.66
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 31.88
  • EEFT 54.39
  • Support Level
  • TMDX $82.70
  • EEFT $101.76
  • Resistance Level
  • TMDX $98.88
  • EEFT $105.00
  • Average True Range (ATR)
  • TMDX 5.52
  • EEFT 2.84
  • MACD
  • TMDX 1.30
  • EEFT 0.34
  • Stochastic Oscillator
  • TMDX 15.58
  • EEFT 68.03

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About EEFT Euronet Worldwide Inc.

Euronet Worldwide Inc is a provider of electronic financial transaction solutions. The company operates an independent network of ATMs in Europe, along with a network for prepaid products such as mobile top-ups, and processes point-of-sale transactions. It operates in three segment EFT Processing Segment, epay Segment, and Money Transfer Segment. Its segment revenue comes from by operating income, electronical financial transaction processing, mainly generates revenue from monthly ATM management fees and currency conversion transactions. It generates the majority if its geographic revenue from the United States of America.

Share on Social Networks: